FDA approves first-of-its-kind ‘living drug’ for childhood leukemia

The Food and Drug Administration on Wednesday approved a groundbreaking cancer treatment for childhood leukemia that uses patients' own genetically altered immune cells to fight the disease. It is the first gene therapy to be allowed in the United States — a “historic” approval, the agency said. The decision clears the Novartis drug, called Kymriah, […]

Related:
FDA cracks down on stem-cell clinics, including one using smallpox vaccine in cancer patients
Does talcum powder cause ovarian cancer?
NIH unit deletes references to climate ‘change’

Share Share Tweet Share Share Share

Home

Thanks For You Reading The Post We are very happy for you to come to our site. Our Website Domain name https://leomedtrends.blogspot.com/.